Johnson and Johnson
Johnson & Johnson seals largest pharmaceutical merger of the year by purchasing Momenta for $6.5 billion
August 20, 2020Business Services, Sales and Marketing Johnson and Johnson, Momenta
Johnson & Johnson is set to buy the Cambridge based Momenta Pharmaceuticals for $6.5 billion, making it the largest pharmaceutical …
US to pay Johnson and Johnson $1 billion for COVID-19 vaccine
August 6, 2020Business Services COVID-19, J&J, JJ, Johnson and Johnson, coronavirus
The US will pay Johnson and Johnson more than $1 billion to create 100 million doses of COVID-19 vaccine. The …
Johnson & Johnson loses bid to overturn baby powder cancer case
June 24, 2020Research and Development Johnson and Johnson, talc, talc powder
Johnson & Johnson have had a bid to overturn a verdict that blamed the company’s baby powder for giving women …
Top Ten most popular articles on Pharmafile.com this week
February 28, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Johnson and Johnson, Wuhan Coronavirus, coronavirus
The coronavirus continues to spread across the globe as the US launch their first trials for Gilead’s ebola drug remdesivir …
US Department of Justice investigate J&J over Baby Powder allegations
February 22, 2019Medical Communications Cancer, J&J, JJ, Johnson and Johnson, USA, asbestos, oncology, talc
The Justice Department and US Securities and Exchanges Commission are investigation healthcare giant Johnson & Johnson over allegations that Johnson’s …
US court overturns J&J’s Zytiga patent in combination with prednisone
October 29, 2018Sales and Marketing J&J, JJ, Johnson and Johnson, Zytiga, court, generic, prednisone
A court in New Jersey has invalidated Johnson & Johnson’s patent on the prostate cancer drug Zytiga when used in …
J&J pledges to end global TB pandemic
September 25, 2018Manufacturing and Production J&J, JJ, Johnson and Johnson, TB, access, tuberculosis
Johnson and Johnson have announced that they are launching a 10-year initiative aimed at helping to end tuberculosis, the world’s …
J&J ordered to pay $4.68 billion to talc-powder plaintiffs
July 13, 2018Medical Communications J&J, JJ, Johnson and Johnson, legal, talc powder
A Missouri jury has ordered the New Jersey-based healthcare company Johnson and Johnson to pay $4.69 billion to 22 women …
J&J reportedly poised to acquire Europe’s biggest biotech
November 25, 2016Sales and Marketing Actelion, J&J, JJ, Johnson and Johnson, acquisition
Johnson & Johnson could be eyeing a takeover of Swiss biotech Actelion, Europe’s biggest biotech, according to insiders, Bloomberg has …
J&J loses Remicade patent fight, pledges to continue fight against biosimilars
August 18, 2016Research and Development, Sales and Marketing Johnson and Johnson, Remicade, biosimilar, biosimilars, infliximab, patent
Johnson and Johnson has announced that it has lost in a patent dispute between biosimilar makers Celltrion and Hospira, relating …
J&J boosted by pharma revenue in Q2 results
July 20, 2016Research and Development 2016, Johnson and Johnson, Q2, results
Shares at Johnson and Johnson have reached a record high of over $125 after pharma revenues helped to raise full …
Johnson & Johnson hit by fall in 2015 sales
January 27, 2016Research and Development, Sales and Marketing Janssen, Johnson and Johnson, financial results, revenue, sales
Full year sales at the healthcare giant Johnson & Johnson fell by 6% in 2015, to just over $70 billion, …
Patients sue J&J for $800m for ‘hiding antibiotic side effects’
January 22, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Janssen, Johnson and Johnson, Levaquin, Margaret Hamburg, lawsuit, levofloxacin
Six users of Johnson & Johnson’s antibiotic Levaquin are to sue the company for up to $870 million, claiming the …
J&J to cut up to 3,000 jobs in key business unit
January 20, 2016Manufacturing and Production, Research and Development Jobs, Johnson and Johnson, pharmajobs, redundancies
Johnson & Johnson has announced a restructuring of its medical devices business unit that could result in up to 3,000 …
J&J and Purdue settle Kentucky lawsuits for $39.5 million
December 24, 2015Sales and Marketing Johnson and Johnson, Kentucky, OxyContin, Purdue Pharma, Risperdal, lawsuits
Johnson & Johnson and Purdue Pharma have settled separate lawsuits with the US state of Kentucky for a total of …
Latest content
Five Facts about cardiovascular disease
